Development of Magnetic Resonance (MR) Simulation for Treatment Planning
This study has been completed.
Sponsor:
Alberta Health Services
Information provided by (Responsible Party):
Alberta Health Services
ClinicalTrials.gov Identifier:
NCT00314496
First received: April 11, 2006
Last updated: January 5, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Retrospectively have access to MR images of patients to develop software that:
- segment images
- convert MR values to electron density and then
- entered into a dose calculation system
The project involves software development of data that is already available. No intervention is made at this point.
| Condition |
|---|
|
Healthy |
| Study Type: | Observational |
| Study Design: | Time Perspective: Retrospective |
| Official Title: | Development of MR Simulation for Treatment Planning |
Further study details as provided by Alberta Health Services:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Adult patient with conform histological diagnosis of glioblastoma multiforme signed the consent forms and were willing to go for curative radiation treatment with temozolomide
Criteria
Inclusion Criteria:
- Subject 18 years of age and older
Contacts and Locations More Information
No publications provided
| Responsible Party: | Alberta Health Services |
| ClinicalTrials.gov Identifier: | NCT00314496 History of Changes |
| Other Study ID Numbers: | EX-0004 |
| Study First Received: | April 11, 2006 |
| Last Updated: | January 5, 2012 |
| Health Authority: | Canada: Health Canada |
ClinicalTrials.gov processed this record on May 19, 2013